The EPHMRA/Intellus ATC Classification Committee is embarking on a pivotal reorganization of the L-class within the Anatomical Classification (ATC) system. This significant change aims to better distinguish antineoplastic (oncology) therapies from immunological products, creating a clearer and more adaptable framework for emerging innovations...

Artificial Intelligence (AI) and Large Language Models (LLMs) are rapidly penetrating healthcare in North America, Europe and Asia. Current and immediately likely applications range from drug discovery and manufacture, through diagnosis and treatment to patient management and adherence. In particular, AI will be essential to offset the great...

Healthcare costs rise in real terms because of continual innovation, largely driven by the US industry and FDA / Medicare acceptance of new products as standard of care. Less prosperous industrial economies are struggling to finance new products. This article focuses on the UK but is applicable across all industrial countries.

Black women face unique challenges entering and advancing in clinical research, despite the field’s rapid growth and need for talent. An industry study uncovered how mentorship and networking are critical tools for overcoming barriers and driving inclusion.

The healthcare industry is evolving at an unprecedented pace. With advancements in technology and the rise of Generative AI (GenAI), decision-makers are under increasing pressure to act quickly. However, speed should not come at the cost of strategic insight. Read on about why market research matters now more than ever...